STAAR Surgical’s planned sale to Alcon collapsed on January 6, 2026 after shareholders rejected the revised all-cash merger ...

Staar Surgical CEO Stephen Farrell and Board of Directors Chair Elizabeth Yeu have stepped down from the company’s board, ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity ...

Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

STAAR Surgical (STAA) said that Neal C. Bradsher and Richard T. LeBuhn of Broadwood Partners and Christopher Wang of Yunqi ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

As part of the cooperation agreement, Staar Chair Elizabeth Yeu and Chief Executive Stephen Farrell have stepped down as members of the board, while Farrell will remain CEO until Jan. 31. The board ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood ...

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a ...